Infinity Pharmaceuticals Inc (INFIQ)
0.00
USD |
OTCM |
May 10, 16:00
Infinity Pharmaceuticals Max Drawdown (5Y): 100.00% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 100.00% |
| March 31, 2024 | 100.00% |
| February 29, 2024 | 100.00% |
| January 31, 2024 | 100.00% |
| December 31, 2023 | 99.96% |
| November 30, 2023 | 99.95% |
| October 31, 2023 | 99.93% |
| September 30, 2023 | 99.77% |
| August 31, 2023 | 98.53% |
| July 31, 2023 | 97.63% |
| June 30, 2023 | 97.44% |
| May 31, 2023 | 97.44% |
| April 30, 2023 | 97.44% |
| March 31, 2023 | 97.01% |
| February 28, 2023 | 96.01% |
| January 31, 2023 | 94.78% |
| December 31, 2022 | 94.78% |
| November 30, 2022 | 95.94% |
| October 31, 2022 | 96.07% |
| September 30, 2022 | 96.59% |
| August 31, 2022 | 96.59% |
| July 31, 2022 | 97.56% |
| June 30, 2022 | 97.90% |
| May 31, 2022 | 98.12% |
| April 30, 2022 | 98.12% |
| Date | Value |
|---|---|
| March 31, 2022 | 98.12% |
| February 28, 2022 | 98.12% |
| January 31, 2022 | 98.12% |
| December 31, 2021 | 98.12% |
| November 30, 2021 | 98.12% |
| October 31, 2021 | 98.12% |
| September 30, 2021 | 98.12% |
| August 31, 2021 | 98.15% |
| July 31, 2021 | 98.15% |
| June 30, 2021 | 98.15% |
| May 31, 2021 | 98.15% |
| April 30, 2021 | 98.15% |
| March 31, 2021 | 98.15% |
| February 28, 2021 | 98.15% |
| January 31, 2021 | 98.15% |
| December 31, 2020 | 98.15% |
| November 30, 2020 | 98.15% |
| October 31, 2020 | 98.15% |
| September 30, 2020 | 98.15% |
| August 31, 2020 | 98.15% |
| July 31, 2020 | 98.15% |
| June 30, 2020 | 98.15% |
| May 31, 2020 | 98.15% |
| April 30, 2020 | 98.15% |
| March 31, 2020 | 98.15% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
94.78%
Minimum
Dec 2022
100.00%
Maximum
Mar 2024
98.04%
Average
98.15%
Median
May 2019
Max Drawdown (5Y) Benchmarks
| Athersys Inc | 100.00% |
| Merck & Co Inc | 27.26% |
| MEI Pharma Inc | 95.76% |
| Humanigen Inc | 100.0% |
| Bristol-Myers Squibb Co | 42.61% |